PNC Financial Services Group
OREX

PNC Financial Services Group’s Orexigen Therapeutics, Inc. OREX Stock Holding History

PNC Financial Services Group’s Portfolio OREX Stock Details OREX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-10
Closed – – 4398
2017
Q2 		$0 Buy
+10
New +$30 ﹤0.01% 4355
2016
Q3 		– Sell
-86
Closed – – 4681
2016
Q2 		$0 Sell
86
-3
-3% -$14 ﹤0.01% 4726
2016
Q1 		$1K Buy
89
+3
+3% +$39 ﹤0.01% 4480
2015
Q4 		$1K Sell
86
-254
-75% -$6.06K ﹤0.01% 4437
2015
Q3 		$7K Buy
340
+3
+0.9% +$103 ﹤0.01% 3868
2015
Q2 		$17K Buy
337
+57
+20% +$3.41K ﹤0.01% 3585
2015
Q1 		$22K Buy
280
+11
+4% +$682 ﹤0.01% 3476
2014
Q4 		$16K Hold
269
– – ﹤0.01% 3240
2014
Q3 		$11K Hold
269
– – ﹤0.01% 3267
2014
Q2 		$17K Hold
269
– – ﹤0.01% 2997
2014
Q1 		$17K Buy
269
+34
+14% +$2.3K ﹤0.01% 2910
2013
Q4 		$13K Hold
235
– – ﹤0.01% 2933
2013
Q3 		$14K Hold
235
– – ﹤0.01% 3084
2013
Q2 		$14K Buy
+235
New +$14.5K ﹤0.01% 2961

Other funds holding OREX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
OWIM
Old West Investment Management Los Angeles, California $923M AUM 112.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PNC Financial Services Group's OREX Position: Q3 2017 in Review

PNC Financial Services Group sold out of Orexigen Therapeutics, Inc. (OREX) in Q3 2017, closing a stake of 10 shares.

PNC Financial Services Group first reported a position in OREX in Q2 2013 and held it in 14 quarters. The position peaked at $22K in Q1 2015. 42 funds tracked by Wall St. Rank hold OREX as of Q3 2017.

  • PNC Financial Services Group reported no remaining Orexigen Therapeutics, Inc. position as of Q3 2017 after selling out during the quarter.
  • PNC Financial Services Group sold 10 Orexigen Therapeutics, Inc. shares in Q3 2017.
  • PNC Financial Services Group first reported a position in Orexigen Therapeutics, Inc. in Q2 2013 and held it in 14 quarters.
  • PNC Financial Services Group's Orexigen Therapeutics, Inc. position peaked at $22K in Q1 2015.
  • 42 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q3 2017.

Based on PNC Financial Services Group's 13F filing for Q3 2017, filed 13 Nov 2017.